Minjeong Lee is a senior scientist of Analytical Development Group in the CDO Center, where she has been responsible for analytical method development and the establishment of antibody-based platform methods. Prior to her current role, she worked on biopharmaceutical production processes within the CMO Purification Group. Throughout her career, she has gained deep expertise in biopharmaceutical processes and antibody-based method development in accordance with ICH guidelines. She holds a master's degree from Seoul National University.